| Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys N Xu, S Kwon, DH Abbott, DH Geller, DA Dumesic, R Azziz, X Guo, ... PloS one 6 (11), e27286, 2011 | 176 | 2011 |
| A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism N Xu, Y Qin, RH Reindollar, SPT Tho, PG McDonough, LC Layman The Journal of Clinical Endocrinology & Metabolism 92 (3), 1155-1158, 2007 | 131 | 2007 |
| Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells H Chen, M Li, N Xu, N Ng, E Sanchez, CM Soof, S Patil, K Udd, S Bujarski, ... Leukemia research 81, 62-66, 2019 | 129* | 2019 |
| Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity MR Jones, MA Brower, N Xu, J Cui, E Mengesha, YDI Chen, KD Taylor, ... PLoS genetics 11 (8), e1005455, 2015 | 121 | 2015 |
| Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation N Xu, R Azziz, MO Goodarzi Fertility and sterility 94 (2), 781-783. e1, 2010 | 116 | 2010 |
| Response to mRNA vaccination for COVID-19 among patients with multiple myeloma SD Stampfer, MS Goldwater, S Jew, S Bujarski, B Regidor, D Daniely, ... Leukemia 35 (12), 3534-3541, 2021 | 95 | 2021 |
| Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome N Xu, HG Kim, B Bhagavath, SG Cho, JH Lee, K Ha, I Meliciani, W Wenzel, ... Fertility and sterility 95 (5), 1613-1620. e7, 2011 | 83 | 2011 |
| Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes N Xu, AK Chua, H Jiang, NA Liu, MO Goodarzi Molecular endocrinology 28 (8), 1329-1336, 2014 | 69 | 2014 |
| Function and Hormonal Regulation of GATA3 in Human First Trimester Placentation B Lee, LL Kroener, N Xu, ET Wang, A Banks, J Williams III, MO Goodarzi, ... Biology of reproduction 95 (5), 113, 1-9, 2016 | 52 | 2016 |
| KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans B Bhagavath, N Xu, M Ozata, RL Rosenfield, DP Bick, RJ Sherins, ... MHR: Basic science of reproductive medicine 13 (3), 165-170*, 2007 | 50 | 2007 |
| Association of CYP3A7* 1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome MO Goodarzi, N Xu, R Azziz The Journal of Clinical Endocrinology & Metabolism 93 (7), 2909-2912, 2008 | 41 | 2008 |
| Steroidogenic Regulatory Factor FOS Is Underexpressed in Polycystic Ovary Syndrome (PCOS) Adipose Tissue and Genetically Associated with PCOS Susceptibility MR Jones, G Chazenbalk, N Xu, AK Chua, T Eigler, E Mengesha, ... The Journal of Clinical Endocrinology & Metabolism 97 (9), E1750-E1757, 2012 | 40 | 2012 |
| Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome MO Goodarzi, N Xu, J Cui, X Guo, YI Chen, R Azziz Human reproduction 23 (5), 1214-1219, 2008 | 35 | 2008 |
| NELF is a nuclear protein involved in hypothalamic GnRH neuronal migration N Xu, B Bhagavath, HG Kim, L Halvorson, RS Podolsky, LP Chorich, ... Molecular and cellular endocrinology 319 (1-2), 47-55, 2010 | 28 | 2010 |
| Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand‐1 (PD‐L1) expression and increases anti‐tumour effects of T cells in multiple myeloma H Chen, M Li, N Ng, E Yu, S Bujarski, Z Yin, M Wen, T Hekmati, D Field, ... British Journal of Haematology 192 (3), 568-576, 2021 | 22 | 2021 |
| Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays N Xu, RH Podolsky, P Chudgar, LP Chorich, C Liu, PG McDonough, ... American journal of obstetrics and gynecology 192 (4), 1274-1282, 2005 | 17 | 2005 |
| Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome N Xu, DH Geller, MR Jones, VA Funari, R Azziz, MO Goodarzi Journal of clinical & translational endocrinology 2 (3), 99-104, 2015 | 16 | 2015 |
| Baseline and changes in serum B-cell maturation antigen levels rapidly indicate changes in clinical status among patients with relapsed/refractory multiple myeloma starting new … S Bujarski, K Udd, C Soof, H Chen, TM Spektor, T Safaie, M Li, J Stern, ... Targeted oncology 16 (4), 503-515, 2021 | 15 | 2021 |
| Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome N Xu, KD Taylor, R Azziz, MO Goodarzi Fertility and sterility 94 (1), 255-260. e2, 2010 | 13 | 2010 |
| The JAK inhibitor blocks PD-L1, PD-L2 and CD44 expression in multiple myeloma (MM) and sensitizes MM cells to lenalidomide and steroids H Chen, M Li, E Sanchez, CM Soof, S Bujarski, N Ng, J Cao, T Hekmati, ... Blood 132, 1910, 2018 | 8 | 2018 |
